BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9619735)

  • 21. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mastocytosis: an unusual clonal disorder of bone marrow-derived hematopoietic progenitor cells.
    Horny HP
    Am J Clin Pathol; 2009 Sep; 132(3):438-47. PubMed ID: 19687320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow mastocytosis associated with an undifferentiated extramedullary tumor of hemopoietic origin.
    Horny HP; Kaiserling E; Sillaber C; Walchshofer S; Valent P
    Arch Pathol Lab Med; 1997 Apr; 121(4):423-6. PubMed ID: 9140315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
    Sotlar K; Saeger W; Stellmacher F; Stahmer J; Jäckle S; Valent P; Horny HP
    J Clin Pathol; 2006 Aug; 59(8):875-8. PubMed ID: 16873565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
    Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
    J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis.
    Sperr WR; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Feb; 127(2):140-2. PubMed ID: 11919425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mastocytosis: classification, diagnosis, and clinical presentation.
    Castells MC
    Allergy Asthma Proc; 2004; 25(1):33-6. PubMed ID: 15055560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val.
    Sperr WR; Walchshofer S; Horny HP; Födinger M; Simonitsch I; Fritsche-Polanz R; Schwarzinger I; Tschachler E; Sillaber C; Hagen W; Geissler K; Chott A; Lechner K; Valent P
    Br J Haematol; 1998 Dec; 103(3):740-9. PubMed ID: 9858225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.
    Valent P; Escribano L; Parwaresch RM; Schemmel V; Schwartz LB; Sotlar K; Sperr WR; Horny HP
    Int Arch Allergy Immunol; 1999 Sep; 120(1):1-7. PubMed ID: 10529583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients.
    Kettelhut BV; Parker RI; Travis WD; Metcalfe DD
    Am J Clin Pathol; 1989 May; 91(5):558-62. PubMed ID: 2470248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous mastocytosis in adults. evaluation of 14 patients with respect to systemic disease manifestations.
    Tebbe B; Stavropoulos PG; Krasagakis K; Orfanos CE
    Dermatology; 1998; 197(2):101-8. PubMed ID: 9732155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biology, classification and treatment of human mastocytosis.
    Valent P
    Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study.
    Chines A; Pacifici R; Avioli LV; Teitelbaum SL; Korenblat PE
    J Clin Endocrinol Metab; 1991 Jan; 72(1):140-4. PubMed ID: 1986013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic Mastocytosis Associated with "Smoldering" Multiple Myeloma.
    Zanelli M; Ricci S; Zizzo M; Sanguedolce F; De Giorgi F; Palicelli A; Martino G; Ascani S
    Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33430341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Isolated bone marrow mastocytosis: a rare cause of osteoporosis not to be missed].
    Van Linthoudt D; Olah AJ; Humair L; Ott H
    Schweiz Rundsch Med Prax; 1994 Feb; 83(7):189-92. PubMed ID: 8184244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG-PET/CT findings in systemic mastocytosis: a French multicentre study.
    Djelbani-Ahmed S; Chandesris MO; Mekinian A; Canioni D; Brouzes C; Hanssens K; Pop G; Durieu I; Durupt S; Grosbois B; Besnard S; Tournilhac O; Beyne-Rauzy O; Agapé P; Delmer A; Ranta D; Jeandel PY; Georgin-Lavialle S; Frenzel L; Damaj G; Eder V; Lortholary O; Hermine O; Fain O; Soussan M
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2013-20. PubMed ID: 26140850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
    Zheng Y; Nong L; Liang L; Wang W; Li T
    Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mastocytosis and co-existent non-Hodgkin's lymphoma and myeloproliferative disorders.
    Hutchinson RM
    Leuk Lymphoma; 1992 May; 7(1-2):29-36. PubMed ID: 1472931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
    Ustun C; Corless CL; Savage N; Fiskus W; Manaloor E; Heinrich MC; Lewis G; Ramalingam P; Kepten I; Jillella A; Bhalla K
    Leuk Res; 2009 May; 33(5):735-41. PubMed ID: 18986703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.